India / 200% Pharma Sector Budget Boost; 3x Industry Growth in Next Decade; Pfizer Vaccine Rebuffed
The latest news from Indian pharma, including a 200 percent boost for the country’s pharmaceutical industry in…
Dr. Reddy’s commenced its generics business in India in 1986 and is today a trusted name in the healthcare industry consistently serving the needs of millions of patients with high quality, affordable and innovative medicines across therapy areas.
As a fully integrated pharmaceutical company, Dr Reddy’s provides medicines through three core businesses:
Pharmaceutical Services and Active Ingredients, comprising our Active Pharmaceuticals and Custom Pharmaceuticals businesses;
– Global Generics, which includes branded and unbranded generics; and
– Proprietary Products, which includes New Chemical Entities (NCEs), Differentiated Formulations,
-Biopharmaceuticals
The latest news from Indian pharma, including a 200 percent boost for the country’s pharmaceutical industry in…
The USD 41 billion Indian pharma industry, the world’s third largest by volume and 13th largest by value, stands…
Six Indian pharma and biotech firms have joined the global race to develop a vaccine for COVID-19 with…
COVID-19 restrictions have severely hampered multinational pharma companies who rely on India for generics and…
A recent IQVIA report highlights the increasing importance of Indian firms to the USA’s burgeoning generic…
The ongoing coronavirus outbreak and the subsequent shutdown of factories in China is having severe repercussions…
Below is a selection of the top stories in Indian pharma from recent months, ranging from efforts to counter the…
Biocon, the first Indian company to have a biosimilar drug approved in the US, is taking another step forward with…
The state of Gujarat proudly stands as India’s main pharmaceutical hub, accounting for over 33 percent of the…
Unlike many of his pharma peers, Vivek Sharma worked in operations and finance for two decades before joining the…
The pharmaceutical industries of China and India, historically focused on their large domestic markets and exports…
Aditya Bhattacharji is Healthcare Practice Head at Eurasia Group. In this article, he looks at India’s…